Glypican-3 as a Radiotheranostic Target for Neuroendocrine Prostate Cancer. Lee W, Chung JY, Baidoo KE, Nambiar D, et al. Eur Urol 2025 May 21:S0302-2838(25)00284-2. doi: 10.1016/j.eururo.2025.

Read + Share

Amedeo Smart

Independent Medical Education

Lee W, Chung JY, Baidoo KE, Nambiar D, et al. Glypican-3 as a Radiotheranostic Target for Neuroendocrine Prostate Cancer. Eur Urol 2025 May 21:S0302-2838(25)00284-2. doi: 10.1016/j.eururo.2025.
PMID: 40404528